What is the Alembic Pharmaceuticals Ltd FII shareholding?

Foreign Institutional Investors (FIIs) hold 4.55% of the total equity shares of Alembic Pharmaceuticals Ltd.

What is the Alembic Pharmaceuticals Ltd DII shareholding?

Domestic Institutional Investors (DIIs) hold 15.43% of the total equity shares of Alembic Pharmaceuticals Ltd.

How has the Alembic Pharmaceuticals Ltd promoter holding changed?

The promoter holding in Alembic Pharmaceuticals Ltd changed from 69.87% to 69.87% during the latest reported period.

How has the Alembic Pharmaceuticals Ltd FII holding changed?

The FII holding in Alembic Pharmaceuticals Ltd changed from 4.18% to 4.55% during the latest reported period.

How has the Alembic Pharmaceuticals Ltd DII holding changed?

The DII holding in Alembic Pharmaceuticals Ltd changed from 15.94% to 15.43% during the latest reported period.

Who are the major shareholders of Alembic Pharmaceuticals Ltd?

The major shareholders of Alembic Pharmaceuticals Ltd may include promoters, institutional investors and other significant shareholders holding substantial equity stakes.

Alembic Pharmaceuticals Ltd Shareholding Pattern: Promoters, FII, DII & Public

Q: What is the Alembic Pharmaceuticals Ltd public shareholding?

Public shareholders hold 10.15% of the total equity shares of Alembic Pharmaceuticals Ltd as per the latest available data.

Alembic Pharmaceuticals Ltd Share Price

Detail Overview

Pharmaceuticals - Indian - Bulk Drugs & Formln LrgNSE

₹760.10

-21.20(-2.71%)

As on 23 Oct 2026 at 15:59

As of 23 Oct 2026 at 15:59, Alembic Pharmaceuticals Ltd is trading at ₹760.10. The 52-week range stands at ₹635.80–₹998.00, with a market cap of ₹14.91 thousand crore. At a P/E of 18.90 and a dividend yield of 1.58%, it is a mid-cap stock in the Pharmaceuticals sector.